Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
Medical News Article on Headache and Migraine Therapy
Reports outline headache and migraine therapy study results from Merck & Company, Inc.
2009 JUN 29 -- Fresh data on headache and migraine are presented in the report 'Age effects on placebo response rates in clinical trials of acute agents for migraine: pooled analysis of rizatriptan trials in adults.' "This study examined the effect of age on placebo response rates in rizatriptan trials in adults. Data from eight rizatriptan adult trials involving patients treating moderate/severe migraine attacks with rizatriptan 5 mg (N=1819), rizatriptan 10 mg (N=2046) or placebo (N=1322) were pooled for post hoc analysis," scientists in the United States report.
"Logistic regression was used to model 2-h pain relief (reduction to mild or none) and...
In order to view the entire article, please read your options to the right
